JFL Life Sciences
add_icon

JFL Life Sciences

10.25
-0.50
(-4.65%)
Market Cap
67.64 Cr
PE Ratio
14.73
Volume
24,000.00
Day High - Low
10.75 - 10.25
52W High-Low
22.20 - 10.00
ann
Q3 Quarterly Results are out. Check out the updated financials14 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
67.64 Cr
EPS
1.26
PE Ratio
14.73
PB Ratio
0.94
Book Value
11.39
EBITDA
8.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
10.54
Debt to Equity
0.22
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,806.80
#1 4,33,511.84
39.98
#1 54,729.00
9.71
#1 10,980
16.07
70.29
6,106.50
1,62,108.39
67.21
9,712.00
18.67
2,191
-1.02
49.00
4,397.50
1,48,831.38
66.21
11,539.40
6.99
1,911
26.24
68.79
1,292.70
1,07,892.67
19.93
33,741.20
16.73
5,725
-15.28
59.78
1,318.40
1,06,496.63
23.61
28,409.50
7.12
5,291
-57.18
43.23
2,324.00
1,06,160.04
23.07
22,909.50
13.74
3,306
#1 37.44
67.87
908.65
91,431.45
#1 18.35
23,511.00
18.55
4,615
-0.32
52.66
2,131.10
87,972.89
50.56
12,744.20
#1 20.90
2,007
7.65
55.18
1,308.80
76,015.32
21.89
32,345.60
9.43
3,484
7.59
70.43
5,387.00
64,409.67
26.89
13,458.30
3.70
2,216
1.90
43.98
Growth Rate
Revenue Growth
74.31 %
Net Income Growth
27.27 %
Cash Flow Change
-141.97 %
ROE
13.58 %
ROCE
38.94 %
EBITDA Margin (Avg.)
-7.66 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
32
30
33
35
45
47
82
80
Expenses
31
28
31
28
39
42
74
71
EBITDA
1
2
2
6
6
5
8
10
Operating Profit %
4 %
6 %
7 %
16 %
9 %
10 %
10 %
13 %
Depreciation
0
0
0
0
0
0
1
1
Interest
1
1
1
2
1
1
1
1
Profit Before Tax
0
1
1
4
4
4
6
7
Tax
0
0
0
1
1
1
2
2
Net Profit
0
0
1
3
3
3
4
5
EPS in ₹
0.59
0.66
0.89
4.12
2.90
1.00
1.26
1.50

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
16
24
29
48
49
57
72
Fixed Assets
3
5
7
7
7
13
12
Current Assets
14
18
21
39
41
44
60
Capital Work in Progress
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
Other Assets
14
19
23
41
42
44
60
Total Equity & Liabilities
16
24
29
48
49
57
72
Current Liabilities
8
18
14
28
15
21
32
Non Current Liabilities
3
1
8
9
2
1
1
Total Equity
5
5
7
11
32
36
40
Reserve & Surplus
5
5
6
3
21
25
7
Share Capital
0
0
1
8
11
11
33

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
-0
0
-0
0
0
Investing Activities
-1
-3
-2
-1
1
-6
0
Operating Activities
-3
3
-6
2
-9
8
-4
Financing Activities
4
-0
7
-2
8
-2
4

Share Holding

% Holding
Apr 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
92.52 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
27.69 %
29.90 %
28.48 %
28.80 %
28.06 %
28.37 %
28.77 %
28.95 %
28.88 %
28.54 %
Others
7.48 %
4.84 %
2.64 %
4.06 %
3.73 %
4.47 %
4.16 %
3.76 %
3.58 %
3.66 %
3.99 %
No of Share Holders
21
1,260
921
873
832
825
966
997
1,022
998
991

Technical Indicators

RSI(14)
Neutral
52.20
ATR(14)
Less Volatile
0.46
STOCH(9,6)
Neutral
66.16
STOCH RSI(14)
Overbought
81.51
MACD(12,26)
Bullish
0.08
ADX(14)
Weak Trend
16.96
UO(9)
Bearish
55.67
ROC(12)
Uptrend And Accelerating
3.37
WillR(14)
Neutral
-29.37